Mometasone Furoate/Olopatadine Hydrochloride

莫米松糠酸酯/盐酸奥洛他定

Report date: 2026/05/27 14:29:21

Base Information

Drug NameMometasone Furoate/Olopatadine Hydrochloride
Drug Alias Name盐酸奥洛他定/莫米松糠酸酯Mometasone+OlopatadineOlopatadine/Mometasone莫米松糠酸酯盐酸奥洛他定盐酸奥洛他定莫米松糠酸酯 +[16] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsHistamine H1 receptor antagonists
TargetsHistamine H1 receptorGlucocorticoid receptor
Therapy Area/IndicationsConjunctivitisRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial +[4] 
Global Approved IndicationsConjunctivitisRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial +[4] 
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryAustralia
Original Approved Date2019/12/11
Country/TerritoryUnited StatesUkraineUzbekistan +[12] 
CombinationsYes Olotadine HydrochlorideMometasone furoate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSeqirusLotus International Pte LtdMenarini Group +[8] 
Inactive CompaniesN/A
Active IndicationsConjunctivitisRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR01
Related LinksN/A